Rare diseases
Investigational molecules
Locations
378 conditions with trials, the busiest first
838 trials across Europe, recruiting first
A study to test if tibulizumab works and is safe for adults with systemic sclerosis
HungaryStudy of IPN10200 compared to placebo for prevention of episodic or chronic migraine in adults
CzechiaStudy of Orticumab in Adults with Previous Heart Attack and High Coronary Inflammation Measured by CT Scan
CzechiaStudy of Rimegepant for Prevention of Menstrual Migraine in Women Aged 18-45 Years
DenmarkStudy on the Effects of Pelacarsen on Heart Disease in Patients with Cardiovascular Conditions
AustriaStudy on Dabigatran and Ticagrelor for Patients with Acute Coronary Syndrome and Atrial Fibrillation Undergoing Heart Procedure
PolandStudy on Rituximab and Cyclophosphamide for Treating ANCA-Associated Vasculitis in Patients Seeking Remission
PolandStudy on Lu AG09222 for Preventing Migraines in Adults Unresponsive to Previous Treatments
BulgariaStudy Comparing AVT16 and Vedolizumab for Adults with Moderate to Severe Ulcerative Colitis
BulgariaStudy on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis
AustriaStudy of Fezolinetant for Hot Flashes in Women with Hormone Receptor-Positive Breast Cancer Receiving Hormone Therapy
CzechiaStudy on Ivabradine for Preventing Heart Injury in Patients with Atherosclerosis Undergoing Noncardiac Surgery
PolandThe therapies tested most often in Vascular disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
